CIK 0001710072 · Large accelerated filer
Edgewise Therapeutics, Inc.
Sign in to watch- Ticker
- EWTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821725586
- Phone
- 720-262-7002
- Business address
- 1715 38TH ST, BOULDER, CO, 80301
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $201,787
- in 1 filing
Net −$201,787. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-11 | Fox Jonathan C Director | Purchase | +10,700 | $18.64 | $199K | 23,702 |
| 2025-04-03 | Thompson Peter A. Director | Purchase | +372,578 | $20.13 | $7.5M | 14,809,075 |
| 2025-04-03 | Thompson Peter A. Director | Purchase | +124,193 | $20.13 | $2.5M | 443,792 |
| 2025-04-03 | ORBIMED ADVISORS LLC Director | Purchase | +372,578 | $20.13 | $7.5M | 14,809,075 |
| 2025-04-03 | ORBIMED ADVISORS LLC Director | Purchase | +124,193 | $20.13 | $2.5M | 443,792 |
| 2024-01-23 | Thompson Peter A. Director | Purchase | +454,545 | $11.00 | $5.0M | 14,436,497 |
| 2024-01-23 | ORBIMED ADVISORS LLC Director | Purchase | +454,545 | $11.00 | $5.0M | 14,436,497 |
| 2023-12-26 | Fox Jonathan C Director | Purchase | +10,857 | $9.30 | $101K | 10,857 |
| 2022-09-16 | Thompson Peter A. Director | Purchase | +484,496 | $10.32 | $5.0M | 13,981,952 |
| 2022-09-16 | ORBIMED ADVISORS LLC Director | Purchase | +484,496 | $10.32 | $5.0M | 13,981,952 |
| 2022-09-14 | Novo Holdings A/S 10% owner | Purchase | +484,496 | $10.32 | $5.0M | 6,071,703 |
| 2022-05-18 | ORBIMED ADVISORS LLC Director | Purchase | +138,000 | $7.21 | $995K | 13,497,456 |
| 2022-05-18 | Thompson Peter A. Director | Purchase | +138,000 | $7.21 | $995K | 13,497,456 |
| 2021-03-30 | ROOT JONATHAN D Director | Purchase | +15,625 | $16.00 | $250K | 15,625 |
| 2021-03-30 | Thompson Peter A. Director | Purchase | +46,875 | $16.00 | $750K | 319,599 |
| 2021-03-30 | Thompson Peter A. Director | Purchase | +312,500 | $16.00 | $5.0M | 13,359,456 |
| 2021-03-30 | ORBIMED ADVISORS LLC Director | Purchase | +46,875 | $16.00 | $750K | 319,599 |
| 2021-03-30 | ORBIMED ADVISORS LLC Director | Purchase | +312,500 | $16.00 | $5.0M | 13,359,456 |
| 2021-03-30 | Novo Holdings A/S 10% owner | Purchase | +625,000 | $16.00 | $10.0M | 5,587,207 |
| 2021-03-30 | Flynn James E 10% owner | Purchase | +625,000 | $16.00 | $10.0M | 3,933,137 |
Page 1 of 1 · 20 trades